Infectious disease is a common cause of death and disability in humans. Microbes are the most frequent infectious agents, and can be either beneficial or pathogenic to their hosts. The study of these microbes is called “clinical microbiology”.
Microbiologists use a variety of laboratory methods to identify, detect, and classify infectious organisms by examining samples such as sputum (mucus coughed up from the lungs), stool (feces), blood, urine, cerebrospinal fluid (CSF), synovial fluid (joints) and wounds. They examine specimens under microscopes; perform biochemical tests on them; extract DNA for sequencing or other molecular biology-based diagnostic testing; or apply culture techniques including forms of micro-fermentation, to produce colonies of the target species.
According to latest research, the global Clinical Microbiology Market will have a market capitalization of 20.1(USD Billion) by 2028 – a growth rate of 6.9% CAGR over the period from 2021 to 2028. According to the report, clinical microbiology is experiencing remarkable advances in deploying of genome sequencing-based assays, characterization assays, genome sequencing-based assays, and mass-spectrometry-based detection.
As per Center for disease control and prevention report, nearly about 9,000 tuberculosis cases, 51,000 salmonella cases, 33,400 Lyme disease incidences, and 400 meningococcal cases were found in the U.S. in year 2014. For the record, American Cancer Society reported nearly 10, 00,000 cancer cases in the country in 2017. Hence, large occurrence of ailments requiring clinical tests are utilized as key diagnostics tools and this is likely to accentuate growth of clinical microbiology market in foreseeable future.
Advancements in laboratory automation and information systems linkage for big data and AI approaches are also introduced in clinical microbiology domain in recent years. Apparently, quick detection of microorganisms in clinical microbiology laboratory can prove to be of high significance for choosing optimal patient management strategies to treat fungal, bacterial, and mycobacterial infections. Moreover, clinical microbiology is based on skilled & technical workforce for processing as well as interpreting outcomes from clinical specimens.
Growing occurrence of contagious diseases such as COVID-19 and technological breakthroughs in disease diagnostics methods will steer growth of clinical microbiology industry over forthcoming years. Need for quick diagnosis of infectious ailments will prompt market size.
In addition to this, rise in funding of research activities for developing pathogen specific diagnostic kits, rise in acceptance of novel genomic methods, surging use of clinical microbiology items in diagnostic units & research labs, and massive allocation of funds by government for drug development & drug discovery will elicit growth of clinical microbiology market over forecasting years.
Thriving medical tourism industry is set to steer demand for monitoring tests in countries such as Thailand, India, Malaysia, and China, thereby driving clinical microbiology market trends in Asia Pacific zone. In addition to this, easy availability of adept workforce at minimal costs along with presence of robust manufacturing base in countries such as Japan and China will promulgate expansion of clinical microbiology industry in Asia Pacific over assessment period. In addition to this, giant drug & medical equipment manufacturing firms are shifting their production bases in Asia, thereby resulting in increment in proceeds of clinical microbiology market. Rapid increase in aging population in countries such as India, Japan, and China along with rise in contagious diseases including tuberculosis, typhoid, hepatitis, and cholera will steer expansion of clinical microbiology industry in the years to come.